




Searching News Database: Ilypsa
HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
HSMN NewsFeed - 8 Jul 2016
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
HSMN NewsFeed - 25 Mar 2014
Calithera Biosciences Appoints William D. Waddill Chief Financial Officer
Calithera Biosciences Appoints William D. Waddill Chief Financial Officer
HSMN NewsFeed - 30 Oct 2007
OncoMed Appoints William D. Waddill Senior Vice President and Chief Financial Officer
OncoMed Appoints William D. Waddill Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 29 Oct 2007
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
HSMN NewsFeed - 12 Dec 2006
Ilypsa Announces Promotion of Gerrit Klaerner, Ph.D. to Senior Vice President and Chief Business Officer
Ilypsa Announces Promotion of Gerrit Klaerner, Ph.D. to Senior Vice President and Chief Business Officer
HSMN NewsFeed - 26 Oct 2006
Ilypsa Announces Appointment of William D. Waddill as Chief Financial Officer
Ilypsa Announces Appointment of William D. Waddill as Chief Financial Officer
HSMN NewsFeed - 27 Apr 2006
Ilypsa and Astellas Enter a Licensing Agreement on ILY101 for Treatment of Hyperphosphatemia in Japan
Ilypsa and Astellas Enter a Licensing Agreement on ILY101 for Treatment of Hyperphosphatemia in Japan